Zyon Ayni: “We Saw Complete Elimination of the Virus in 90% to 100% of Cells”

Zyon Ayni - The Jerusalem Post

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Zyon Ayni, Code Pharma founder and CEO, quoted in The Jerusalem Post about CODIVIR, a drug used to treat HIV with a direct antiviral effect on coronavirus. Ayni said that the goal is to finish the trial in three to six months and then apply for emergency use authorization.

Ayni said: “We saw complete elimination of the virus in 90% to 100% of cells in less than 24 hours. There were no significant side effects from the treatment itself. One hospital there started administering it to COVID-19 patients, too, and they got completely better – some in hours and some in days. The world is in need of an antiviral medication against COVID”.

More To Explore

Zyon Ayni - ynet
Press

Zyon Ayni’s Code Pharma on ynet TV

Codivir, an antiviral medication against COVID-19, was developed by Code Pharma and its Founder and CEO, Zyon Ayni. Dr. Einat Finkelstein, Chief Scientist of the company,